More in­spec­tion trou­ble for Zy­dus just a day af­ter big ac­qui­si­tion

An FDA in­spec­tion at In­dia’s Zy­dus Life­sciences’ fa­cil­i­ty has re­sult­ed in three ob­ser­va­tions, the com­pa­ny re­vealed Thurs­day.

The an­nounce­ment comes af­ter the FDA in­spect­ed the site in Jar­od, Gu­jarat from Feb. 24 to March 10. The news was re­vealed in a let­ter to the Na­tion­al Stock Ex­change of In­dia.

“We are con­fi­dent of ad­dress­ing and re­solv­ing the is­sues to the sat­is­fac­tion of USF­DA,” the note said. “We re­main com­mit­ted to build­ing a qual­i­ty cul­ture across our en­tire man­u­fac­tur­ing net­work, and are com­mit­ted to re­main com­pli­ant with high stan­dards of Good Man­u­fac­tur­ing Prac­tices across our net­work.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER